Home › Mantle Cell Lymphoma › Minnesota › Rochester

Pag-aaral pangklinika para sa Mantle Cell Lymphoma sa Rochester, MN

9 pag-aaral para sa Mantle Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Rochester (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Nagre-recruitPhase 1/2

Research Site, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Nagre-recruitPhase 3

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06742996

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Mayo Clinic - Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Mayo Clinic, Clinical Trials Referral Office, Rochester

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Nagre-recruitObservasyonal na pag-aaral

Mayo Clinic in Rochester, Rochester

Lahat ng edad · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06151730

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT06854003

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Nagre-recruitPhase 2

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 18, 2024 · NCT05910801

Pag-aaral para sa Mantle Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Rochester

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.